Immunotherapy Combination Approaches
At the 1-day Cancer Immunotherapy: A Long Awaited Reality Conference, representatives from biotechnology companies and research clinicians working on immunotherapies discussed the promise of combination immunotherapies in cancer.
Engineered T-Cell Immunotherapy Approaches in Cancer
A personalized form of immunotherapy called adoptive T-cell transfer is moving beyond a few specialized academic centers to biotechnology and pharmaceutical development.
Novel Immunotherapy Approaches Presented at Annual Meeting
Several companies are focusing on boosting T-cell activity against tumors by engineering human cells to produce antigens and adjuvants, which, like vaccines, can prime and modulate an immune response.